135 related articles for article (PubMed ID: 859560)
1. 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters.
Bloomer WD; Adelstein SJ
Nature; 1977 Feb; 265(5595):620-1. PubMed ID: 859560
[No Abstract] [Full Text] [Related]
2. 125I interstitial implants in the RIF-1 murine flank tumor: an animal model for brachytherapy.
Bernstein M; Gutin PH; Weaver KA; Deen DF; Barcellos MH
Radiat Res; 1982 Sep; 91(3):624-37. PubMed ID: 6750681
[No Abstract] [Full Text] [Related]
3. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
Bloomer WD; Adelstein SJ
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
[TBL] [Abstract][Full Text] [Related]
4. Preclinical animal studies with radioiododeoxyuridine.
Kassis AI; Adelstein SJ
J Nucl Med; 1996 Apr; 37(4 Suppl):10S-12S. PubMed ID: 8676195
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
[TBL] [Abstract][Full Text] [Related]
6. Merrill C. Sosman Lecture. The Auger process: a therapeutic promise?
Adelstein SJ
AJR Am J Roentgenol; 1993 Apr; 160(4):707-13. PubMed ID: 8456649
[No Abstract] [Full Text] [Related]
7. 5-(125I)-iododeoxyuridine and the Auger effect: biological consequences and implications for therapy.
Bloomer WD; Adelstein SJ
Pathobiol Annu; 1978; 8():407-21. PubMed ID: 364377
[TBL] [Abstract][Full Text] [Related]
8. Letter: Antineoplastic effect of iodine-125-labelled iododeoxyuridine.
Bloomer WD; Adelstein SJ
Int J Radiat Biol Relat Stud Phys Chem Med; 1975 May; 27(5):509-11. PubMed ID: 1080145
[No Abstract] [Full Text] [Related]
9. On the equivalent dose for Auger electron emitters.
Howell RW; Narra VR; Sastry KS; Rao DV
Radiat Res; 1993 Apr; 134(1):71-8. PubMed ID: 8475256
[TBL] [Abstract][Full Text] [Related]
10. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
Xiao WH; Dupertuis YM; Mermillod B; Sun LQ; de Tribolet N; Buchegger F
Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
[TBL] [Abstract][Full Text] [Related]
11. Radiation quality-dependent bystander effects elicited by targeted radionuclides.
Boyd M; Sorensen A; McCluskey AG; Mairs RJ
J Pharm Pharmacol; 2008 Aug; 60(8):951-8. PubMed ID: 18644188
[TBL] [Abstract][Full Text] [Related]
12. The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells.
Howell RW; Rao DV; Hou DY; Narra VR; Sastry KS
Radiat Res; 1991 Dec; 128(3):282-92. PubMed ID: 1961925
[TBL] [Abstract][Full Text] [Related]
13. Radiotoxicity of 125I-iododeoxyuridine in pre-implantation mouse embryos.
Narra VR; Howell RW; Thanki KH; Rao DV
Int J Radiat Biol; 1991 Sep; 60(3):525-32. PubMed ID: 1679091
[TBL] [Abstract][Full Text] [Related]
14. Biological toxicity of Auger emitters: molecular fragmentation versus electron irradiation.
Hofer KG; Keough G; Smith JM
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):335-54. PubMed ID: 639556
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
Le Mevel BP; Oldham RK; Wells SA; Herberman RB
J Natl Cancer Inst; 1973 Nov; 51(5):1551-8. PubMed ID: 4797027
[No Abstract] [Full Text] [Related]
16. Relative biological effectiveness of 125I sources in a murine brachytherapy model.
Da Silva VF; Gutin PH; Deen DF; Weaver KA
Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2109-11. PubMed ID: 6490435
[TBL] [Abstract][Full Text] [Related]
17. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
Neshasteh-Riz A; Mairs RJ; Angerson WJ; Stanton PD; Reeves JR; Rampling R; Owens J; Wheldon TE
Br J Cancer; 1998; 77(3):385-90. PubMed ID: 9472632
[TBL] [Abstract][Full Text] [Related]
18. Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design.
Narra VR; Howell RW; Harapanhalli RS; Sastry KS; Rao DV
J Nucl Med; 1992 Dec; 33(12):2196-201. PubMed ID: 1460515
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of 5-iododeoxyuridine 1311 in spontaneous C3H mouse mammary tumours.
ROTENBERG AD; BRUCE WR; BAKER RG
Br J Radiol; 1962 May; 35():337-42. PubMed ID: 14494361
[No Abstract] [Full Text] [Related]
20. Quantitation of cytotoxic antitumor antibody in vitro: a microassay with 125I-iododeoxyuridine as a tumor cell label.
Fritze D; Kern DH; Pilch YH
J Natl Cancer Inst; 1974 Nov; 53(5):1403-7. PubMed ID: 4431057
[No Abstract] [Full Text] [Related]
[Next] [New Search]
